Spots Global Cancer Trial Database for aspirin
Every month we try and update this database with for aspirin cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Adjuvant Aspirin Treatment for Colon Cancer Patients | NCT02467582 | Colon Cancer | Aspirin Placebo | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Low-dose Aspirin Therapy for Esophageal Cancer | NCT02326779 | Esophageal Canc... | Acetylsalicylic... | 18 Years - | Zhejiang University | |
| Adjuvant Low Dose Aspirin in Colorectal Cancer | NCT02647099 | Colorectal Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | Karolinska Institutet | |
| Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | NCT00002527 | Colorectal Canc... | aspirin placebo | 30 Years - 74 Years | Alliance for Clinical Trials in Oncology | |
| Combination of Osimertinib and Aspirin to Treat 1st Generation EGFR-TKI Resistance in NSCLC | NCT03543683 | Non-Small Cell ... Non-small Cell ... EGFR T790M | Osimertinib Aspirin | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Aspirin for Prevention of Venous Thromboembolism Among Ovarian Cancer Patients Receiving Neoadjuvant Chemotherapy | NCT04352439 | Venous Thromboe... Ovarian Cancer | Aspirin | 18 Years - | Duke University | |
| Combination of Osimertinib and Aspirin to Treat Osimertinib Resistance Non-small Cell Lung Cancer ( NSCLC) | NCT03532698 | Non-Small Cell ... Non-small Cell ... EGFR T790M | Aspirin Osimertinib | 18 Years - 75 Years | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Peri-operative Aspirin Continuation Versus Discontinuation | NCT02350543 | Hematuria Urinary Bladder... | Aspirin | 18 Years - | Rabin Medical Center | |
| Bendamustine in Combination With Lenalidomide and Dexamethasone in Refractory or Relapsed Multiple Myeloma | NCT01042704 | Myeloma | Bendamustine Lenalidomide Dexamethasone Aspirin Prophylaxis Antibiotic Biweekly Follow... Cyclical Follow... Restaging Post-Treatment ... | 18 Years - | University of Pittsburgh | |
| ASPREE Cancer Endpoints Study | NCT01968798 | Cancer | Aspirin Placebo | 65 Years - | Hennepin Healthcare Research Institute | |
| Regorafenib With Low-dose Chemotherapies and Aspirin Followed by Standard Chemotherapies in Metastatic Colorectal Cancer | NCT05462613 | Metastatic Colo... | quality of life... Blood sample Regorafenib Metronomic chem... Aspirin Bevacizumab FOLFIRI or FOLF... | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | NCT02927249 | Node Positive H... | Placebo Aspirin | 18 Years - 69 Years | Alliance for Clinical Trials in Oncology | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| Efficiency Study of Aspirin to Prevent the Occurrence of Prostate Cancer | NCT02757365 | Prostate Cancer | aspirin Levofloxacin | 50 Years - 70 Years | West China Hospital | |
| Aspirin in Colorectal Cancer Liver Metastases | NCT03326791 | Colorectal Canc... Colorectal Canc... Liver Metastase... | Acetylsalicylic... Placebo Oral Ta... | 18 Years - | Oslo University Hospital | |
| A Randomized, 2x2 Factorial Design Biomarker Prevention Trial of Low-dose ASA and Metformin in Stage I-III Crc Patients | NCT03047837 | Tertiary Preven... | ASA MET Placebo | 18 Years - 80 Years | Ente Ospedaliero Ospedali Galliera | |
| Phase 1-2 Amrubicin in Combo With Lenalidomide + Weekly Dexamethasone in Relapsed/Refractory Multiple Myeloma | NCT01355705 | Multiple Myelom... | Amrubicin Lenalidomide Dexamethasone Aspirin Pegfilgrastim | 18 Years - | Stanford University | |
| Peri-operative Aspirin Continuation Versus Discontinuation | NCT02350543 | Hematuria Urinary Bladder... | Aspirin | 18 Years - | Rabin Medical Center | |
| Acetylsalicylic Acid Compared to Placebo in Treating High-Risk Patients With Subsolid Lung Nodules | NCT02169271 | Current Smoker Former Smoker Multiple Pulmon... Tobacco Use Dis... | Aspirin Laboratory Biom... Placebo | 50 Years - | National Cancer Institute (NCI) | |
| Enoxaparin Versus Aspirin in Patients With Cancer and Stroke | NCT01763606 | Cancer Patients... | Enoxaparin Aspirin | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | NCT02804815 | Cancer Breast Cancer Prostate Cancer Colorectal Canc... Gastro-oesophag... | Aspirin 100mg Aspirin 300mg Placebo 100mg Placebo 300mg | 16 Years - | University College, London | |
| A Study of Low Dose Lenalidomide and Dexamethasone in Relapsed/Refractory Myeloma in Patients at High Risk for Myelosuppression | NCT00482261 | Multiple Myelom... | Lenalidomide dexamethasone aspirin | 18 Years - | Peter MacCallum Cancer Centre, Australia | |
| Enoxaparin Versus Aspirin in Patients With Cancer and Stroke | NCT01763606 | Cancer Patients... | Enoxaparin Aspirin | 18 Years - 85 Years | Memorial Sloan Kettering Cancer Center | |
| ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | NCT05056896 | Colorectal Canc... | Aspirin Placebo | 18 Years - | Massachusetts General Hospital | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| A Phase IIa Randomized, Double-Blinded Clinical Trial of Naproxen or Aspirin for Cancer Immune Interception in Lynch Syndrome | NCT05411718 | T Cells Colorectal Canc... Lynch Syndrome | Naproxen Aspirin | 18 Years - | M.D. Anderson Cancer Center | |
| A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | NCT06378398 | Colorectal Neop... | Omeprazole Aspirin | 18 Years - 75 Years | University of Michigan Rogel Cancer Center | |
| Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | NCT02285738 | Solid Tumor Cancer | Aspirin Simvastatin Observation | 18 Years - | Case Comprehensive Cancer Center | |
| Randomized Trial of Pegylated Interferon Alfa-2a Versus Hydroxyurea in Polycythemia Vera (PV) and Essential Thrombocythemia (ET) | NCT01259856 | High Risk Polyc... High Risk Essen... | PEGASYS Hydroxyurea Aspirin | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Feasibility of ExAblate MRI Guided High Intensity Focused Ultrasound Tx of Soft Tissue Tumors | NCT01965002 | Soft Tissue Neo... | MRgHIFU Aspirin Enoxaparin | 10 Years - | Stanford University | |
| Aspirin in Preventing Disease Recurrence in Patients With Barrett Esophagus After Successful Elimination by Radiofrequency Ablation | NCT02521285 | Barrett Esophag... | Aspirin Laboratory Biom... Placebo Adminis... Questionnaire A... | 18 Years - 75 Years | National Cancer Institute (NCI) | |
| Moxetumomab Pasudotox-tdfk (Lumoxiti(TM)) and Either Rituximab (Rituxan(R)) or Ruxience for Relapsed Hairy Cell Leukemia | NCT03805932 | Hairy Cell Leuk... | Moxetumomab Pas... Rituximab Ruxience Dexamethasone Acetaminophen Diphenhydramine Famotidine Aspirin | 18 Years - | National Institutes of Health Clinical Center (CC) | |
| Add-Aspirin: A Trial Assessing the Effects of Aspirin on Disease Recurrence and Survival After Primary Therapy in Common Non Metastatic Solid Tumours | NCT02804815 | Cancer Breast Cancer Prostate Cancer Colorectal Canc... Gastro-oesophag... | Aspirin 100mg Aspirin 300mg Placebo 100mg Placebo 300mg | 16 Years - | University College, London | |
| Outcome Analysis of Aspirin in Liver Transplantation | NCT04327427 | Liver Transplan... | Aspirin | 18 Years - | University of Zurich | |
| Study of Pembrolizumab, Radiation and Immune Modulatory Cocktail in Cervical/Uterine Cancer | NCT03192059 | Cervical Cancer Endometrial Can... Uterine Cancer | Pembrolizumab Radiation Vitamin D Aspirin Lansoprazole Cyclophosphamid... Curcumin | 18 Years - | University Hospital, Ghent | |
| Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma | NCT02748304 | Hepatocellular ... | control sorafenib aspirin | 18 Years - 75 Years | Fudan University | |
| Trial of Aspirin and Arginine Restriction in Colorectal Cancer | NCT00578721 | Colorectal Canc... | Aspirin | 18 Years - 80 Years | University of California, Irvine | |
| APACC Study:Prospective Study on Aspirin Efficacy in Reducing Colorectal Adenoma Recurrence | NCT00224679 | Colon Adenomas | Aspirin | 18 Years - 75 Years | Assistance Publique - Hôpitaux de Paris | |
| Arsenic Trioxide and Ascorbic Acid Combined With Bortezomib, Thalidomide, and Dexamethasone in Treating Patients With Relapsed or Refractory Multiple Myeloma or Plasma Cell Leukemia | NCT00258245 | Multiple Myelom... | ascorbic acid arsenic trioxid... bortezomib dexamethasone thalidomide Aspirin | 18 Years - | Barbara Ann Karmanos Cancer Institute | |
| Aspirin on CTCs of Advanced Breast and Colorectal Cancer | NCT02602938 | Epithelial-Mese... Circulating Tum... | Aspirin | 18 Years - 75 Years | Zhejiang Provincial People's Hospital | |
| Aspirin and Rintatolimod With or Without Interferon-alpha 2b in Treating Patients With Prostate Cancer Before Surgery | NCT03899987 | Prostate Adenoc... Stage I Prostat... Stage II Prosta... Stage IIA Prost... Stage IIB Prost... Stage IIC Prost... Stage III Prost... Stage IIIA Pros... Stage IIIB Pros... Stage IIIC Pros... | Aspirin Radical Prostat... Recombinant Int... Rintatolimod | 18 Years - | Roswell Park Cancer Institute | |
| A Study of the Effects of Inhibiting Platelet Function on Circulating Cancer Cells in Breast Cancer Patients | NCT00263211 | Breast Neoplasm... | Plavix Aspirin | 18 Years - | Washington University School of Medicine | |
| Adjuvant Low Dose Aspirin in Colorectal Cancer | NCT02647099 | Colorectal Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | Karolinska Institutet | |
| Induction Chemotherapy Plus Chemoradiotherapy With or Without Aspirin in High Risk Rectal Cancer | NCT03170115 | Rectal Cancer, ... Locally Advance... Chemoradiation | Aspirin Placebo Oral Ta... | 18 Years - 75 Years | Instituto Nacional de Cancer, Brazil | |
| Pegylated Interferon Alfa-2a Salvage Therapy in High Risk Polycythemia Vera (PV) or Essential Thrombocythemia (ET) | NCT01259817 | High Risk Polyc... High Risk Essen... | PEGASYS Aspirin | 18 Years - | Icahn School of Medicine at Mount Sinai | |
| Effects of ASA on Prostate Tissue | NCT00234299 | Prostate Cancer | Aspirin Placebo | 45 Years - 74 Years | University of Washington | |
| Barrett's Esophagus - 315 - 3 Way Cross Over | NCT00637988 | Barrett's Esoph... | Esomeprazole Aspirin Rofecoxib | 18 Years - | AstraZeneca | |
| Study of Aspirin in Patients With Vestibular Schwannoma | NCT03079999 | Vestibular Schw... Acoustic Neurom... Neurofibromatos... | Aspirin Placebo | 12 Years - | Massachusetts Eye and Ear Infirmary | |
| A Study to Compare MPR With MP in Newly Diagnosed Multiple Myeloma Subjects 65 Years Old or Older. | NCT00405756 | Newly Diagnosed... | Lenalidomide: D... Melphalan Prednisone Aspirin Placebo Lenalidomide: D... Lenalidomide: O... | 65 Years - | Celgene Corporation | |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | NCT02965703 | Colorectal Aden... | Aspirin Biospecimen Col... Placebo Adminis... Questionnaire A... Rectal Biopsy | 18 Years - | National Cancer Institute (NCI) | |
| ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension | NCT05056896 | Colorectal Canc... | Aspirin Placebo | 18 Years - | Massachusetts General Hospital | |
| Clopidogrel and Aspirin for the Treatment of Polycythemia Vera | NCT00940784 | Polycythemia Ve... | Clopidogrel (Pl... Placebo Aspirin | 18 Years - 81 Years | Icahn School of Medicine at Mount Sinai | |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | NCT03356769 | Tuberous Sclero... Aspirin Epilepsy Cognitive Decli... Skin Lesions | Aspirin AED Placebo | 6 Years - 30 Years | Peking Union Medical College Hospital | |
| Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma | NCT02748304 | Hepatocellular ... | control sorafenib aspirin | 18 Years - 75 Years | Fudan University | |
| ASPREE Cancer Endpoints Study | NCT01968798 | Cancer | Aspirin Placebo | 65 Years - | Hennepin Healthcare Research Institute | |
| Prophylactic Anticoagulation for Catheter-related Thrombosis | NCT04256525 | Venous Thrombos... Prophylactic An... Patients With T... | Rivaroxaban 10m... Aspirin 100mg low molecule he... | 18 Years - 75 Years | Second Affiliated Hospital, School of Medicine, Zhejiang University | |
| Clinical Study of Antiviral and Aspirin Treatment in Liver Cancer After Radical Surgery | NCT01936233 | Hepatocellular ... Recurrence | Aspirin Lamivudine | 18 Years - 75 Years | Fudan University | |
| Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer | NCT00000479 | Cardiovascular ... Cerebrovascular... Coronary Diseas... Heart Diseases Myocardial Infa... Myocardial Isch... Vascular Diseas... | Aspirin Vitamin E Placebo | 45 Years - | Brigham and Women's Hospital | |
| Aspirin as an add-on Treatment of Refractory Epilepsy in Tuberous Sclerosis Complex | NCT03356769 | Tuberous Sclero... Aspirin Epilepsy Cognitive Decli... Skin Lesions | Aspirin AED Placebo | 6 Years - 30 Years | Peking Union Medical College Hospital | |
| Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer | NCT04534218 | Colo-rectal Can... Metastatic Canc... | Regorafenib Cyclophosphamid... Capecitabine Aspirin | 18 Years - | Centre Hospitalier Universitaire de Besancon | |
| Aspirin in Patients With Myocardial Infarction and Thrombocytopenia | NCT00501345 | Thrombocytopeni... Myocardial Infa... | Aspirin | - | M.D. Anderson Cancer Center | |
| Sorafenib Combined With Aspirin to Prevent the Recurrence in High-risk Patients With Hepatocellular Carcinoma | NCT02748304 | Hepatocellular ... | control sorafenib aspirin | 18 Years - 75 Years | Fudan University | |
| Perioperative Platelet Inhibition With Acetylsalicylic Acid in Patients With Resectable Tumors of the Pancreatic Head | NCT05637567 | Pancreatic Canc... | Acetylsalicylic... Placebo | 18 Years - 80 Years | German Cancer Research Center | |
| Osimertinib Combined With Aspirin Neoadjuvant Therapy for Resectable EGFR Mutated NSCLC Patients. | NCT06018688 | Non Small Cell ... EGFR Gene Mutat... | Osimertinib Aspirin | 18 Years - | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | |
| Aspirin on CTCs of Advanced Breast and Colorectal Cancer | NCT02602938 | Epithelial-Mese... Circulating Tum... | Aspirin | 18 Years - 75 Years | Zhejiang Provincial People's Hospital | |
| The Risk of Bleeding After Removal of Large Colorectal Polyps in Patients Taking Aspirin | NCT01549418 | Gastrointestina... | Aspirin (ASA) Placebo | 40 Years - | Maria Sklodowska-Curie National Research Institute of Oncology | |
| A Phase III, Randomized, Study of Aspirin and Esomeprazole Chemoprevention in Barrett's Metaplasia | NCT00357682 | Esophageal Canc... Precancerous Co... | Esomeprazole Esomeprazole Aspirin | 18 Years - | University of Oxford | |
| ASPIRIN Trial Belgium | NCT03464305 | Colon Cancer | acetylsalicylic... Placebo | 45 Years - | University Hospital, Antwerp | |
| Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | NCT02285738 | Solid Tumor Cancer | Aspirin Simvastatin Observation | 18 Years - | Case Comprehensive Cancer Center | |
| Aspirin in Preventing Colorectal Cancer in Patients With Colorectal Adenoma | NCT02965703 | Colorectal Aden... | Aspirin Biospecimen Col... Placebo Adminis... Questionnaire A... Rectal Biopsy | 18 Years - | National Cancer Institute (NCI) | |
| ASPirin Intervention for the REDuction of Colorectal Cancer Risk | NCT02394769 | Colorectal Canc... | Aspirin Placebo for Asp... | 18 Years - 80 Years | Massachusetts General Hospital | |
| DAILY: Vitamin D, Aspirin, ExercIse, Low Saturated Fat Foods StudY in Colorectal Cancer Patients With Minimal Residual Disease | NCT05036109 | Colorectal Canc... Colon Cancer | Aspirin Vitamin D Diet Physical Activi... Behavioral Supp... | 18 Years - | M.D. Anderson Cancer Center | |
| Finding the Best Dose of Aspirin to Prevent Lynch Syndrome Cancers | NCT02497820 | Lynch Syndrome ... | Aspirin | 18 Years - | Tel-Aviv Sourasky Medical Center | |
| Aspirin Improve Survival of N2-3 Nasopharyngeal Carcinoma Patients | NCT03290820 | Nasopharyngeal ... | Radiotherapy Concurrent chem... Aspirin | 18 Years - 70 Years | Sun Yat-sen University | |
| A Trial of Omeprazole and Low Dose Aspirin to Identify Colorectal Biomarkers of Preventive Efficacy | NCT06378398 | Colorectal Neop... | Omeprazole Aspirin | 18 Years - 75 Years | University of Michigan Rogel Cancer Center | |
| Acetylsalicylic Acid and Eflornithine in Treating Patients at High Risk for Colorectal Cancer | NCT00983580 | Adenomatous Pol... | Aspirin Eflornithine Laboratory Biom... Placebo Telephone-Based... | 40 Years - | National Cancer Institute (NCI) | |
| Aspirin in Preventing Recurrence of Cancer in Patients With HER2 Negative Stage II-III Breast Cancer After Chemotherapy, Surgery, and/or Radiation Therapy | NCT02927249 | Node Positive H... | Placebo Aspirin | 18 Years - 69 Years | Alliance for Clinical Trials in Oncology | |
| Study of Aspirin and Exemestane as Adjuvant Treatment in Breast Cancer | NCT01431053 | Breast Neoplasm... | aspirin Exemestane | 50 Years - 80 Years | ChineseAMS | |
| Physiological Effects of Altering Cancer-related Inflammation | NCT01786200 | Colon Cancer | Aspirin Ibuprofen | 18 Years - 75 Years | NHS Greater Glasgow and Clyde | |
| Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis | NCT02285738 | Solid Tumor Cancer | Aspirin Simvastatin Observation | 18 Years - | Case Comprehensive Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
